BioSpace News Archive

Northwest Biotherapeutics (OTCQB: NWBO)(“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that Dr. Marnix Bosch, Chief Technical Officer of NW Bio, is presenting at 11:40 a.m. today at the inaugural Glioblastoma (GBM) Drug Development Summit being held at the Westin Boston Waterfront Hotel in Boston, Massachusetts.

SunRADON, a Sun Nuclear company and the leading provider of Continuous Radon Monitors (CRMs) for commercial and residential purposes, today announced the approval of its 1028™ XP Continuous Radon Monitor by the National Radon Safety Board

Paper includes an overview of the recent Beth Israel Lahey Health merger and some early results

The Epilepsy Foundation announced today that Philip M. Gattone, M.Ed., is stepping down from his position as president and chief executive officer of the Epilepsy Foundation effective December 31, 2019.